|

INCA33890 Clinical Trials

3 actively recruiting trials across 3 locations

Pipeline

Phase 1: 2Phase 3: 1

Top Sponsors

  • Incyte Corporation3

Indications

  • Cancer3
  • Solid Tumors2
  • Metastatic Solid Tumors1
  • CRC (Colorectal Cancer)1
  • Advanced Solid Tumors1

Phoenix, Arizona1 trial

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Mayo Clinic Hospital

Phase 1

Tucson, Arizona1 trial

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

The University of Arizona Cancer Center

Phase 3

Los Angeles, California1 trial

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

The Angeles Clinic and Research Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.